BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2352250)

  • 1. Initial selection of oral contraceptives.
    Reiter SL; Baer LJ
    J Reprod Med; 1990 May; 35(5):547-8. PubMed ID: 2352250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
    Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three triphasic oral contraceptives now available in U.S.
    Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cycle control on low-dose oral contraceptives: a comparative trial.
    Percival-Smith RK; Yuzpe AA; Desrosiers JA; Rioux JE; Guilbert E
    Contraception; 1990 Sep; 42(3):253-62. PubMed ID: 2289388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tri-Norinyl and Ortho-Novum 7/7/7--two triphasic oral contraceptives.
    Med Lett Drugs Ther; 1984 Oct; 26(672):93-4. PubMed ID: 6384752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial.
    Kaunitz AM
    Contraception; 2000 May; 61(5):295-302. PubMed ID: 10906499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for a triphasic oral contraceptive.
    Pasquale SA
    J Reprod Med; 1984 Jul; 29(7 Suppl):560-7. PubMed ID: 6481710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and panic disorder.
    Deci PA; Lydiard RB; Santos AB; Arana GW
    J Clin Psychiatry; 1992 May; 53(5):163-5. PubMed ID: 1592843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
    Sinofsky FE; Pasquale SA
    Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of triphasic and biphasic oral contraceptive preparations on HDL-cholesterol and LDL-cholesterol in young women.
    Percival-Smith RK; Morrison BJ; Sizto R; Abercrombie B
    Contraception; 1987 Feb; 35(2):179-87. PubMed ID: 3595143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative trials of low-dose combined oral contraceptives.
    Edelman DA; Kothenbeutel R; Levinski MJ; Kelly SE
    J Reprod Med; 1983 Mar; 28(3):195-200. PubMed ID: 6854550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.
    Masson S; Franssen E; Hilditch JR; Powell MG
    Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives.
    Garceau RJ; Wajszczuk CJ; Kaunitz AM;
    Contraception; 2000 Dec; 62(6):289-95. PubMed ID: 11239615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The triphasics: insights for effective clinical use.
    Youngkin EQ; Miller LG
    Nurse Pract; 1987 Feb; 12(2):17-8, 23, 26-8. PubMed ID: 3822267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current status of oral contraceptive clinical development in Japan.
    Kuwabara Y
    Int J Fertil; 1989; 34 Suppl():18-20. PubMed ID: 2576251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
    Poindexter AN; Burkman R; Fisher AC; LaGuardia KD
    Int J Fertil Womens Med; 2003; 48(4):163-72. PubMed ID: 13677549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
    Shulman LP; Oleen-Burkey M; Willke RJ
    Contraception; 1999 Oct; 60(4):215-22. PubMed ID: 10640168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial.
    Dunson TR; McLaurin VL; Israngkura B; Leelapattana B; Mukherjee R; Perez-Palacios G; Saleh AA
    Contraception; 1993 Aug; 48(2):109-19. PubMed ID: 8403908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.